Belldegrun Arie
SEC-identified person · CIK 1296549 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Urogen Pharma Ltd. URGN | Director | filed 2019 - 2026 |
| Allogene Therapeutics, Inc. ALLO | Director | filed 2018 - 2026 |
| LB Pharmaceuticals INC LBRX | Officer | filed 2025 - 2025 |
| Kronos Bio, Inc. KRON | Director | filed 2020 - 2025 |
| Soaring Eagle Acquisition Corp. SRNG | Director | filed 2021 - 2024 |
| Kite Pharma, Inc. KITE | Director · Chairman, President and CEO | filed 2014 - 2017 |
| Laurier International INC LRRI.OB | Director | filed 2008 - 2016 |
| SMI Products INC SPDU | Director | filed 2009 - 2011 |
| Srkp 4 INC CGRB | Director | filed 2006 - 2009 |
| Talon Therapeutics, Inc. TLON.OB | Director | filed 2006 - 2009 |
| Paramount Acquisition Corp [PMQC. OB] | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.